Literature DB >> 16764825

Dexamethasone facilitates erythropoiesis in murine embryonic stem cells differentiating into hematopoietic cells in vitro.

Anand S Srivastava1, Sharmeela Kaushal, Rangnath Mishra, Thomas A Lane, Ewa Carrier.   

Abstract

Differentiating embryonic stem (ES) cells are increasingly emerging as an important source of hematopoietic progenitors with a potential to be useful for both basic and clinical research applications. It has been suggested that dexamethasone facilitates differentiation of ES cells towards erythrocytes but the mechanism responsible for sequential expression of genes regulating this process are not well-understood. Therefore, we in vitro induced differentiation of murine ES cells towards erythropoiesis and studied the sequential expression of a set of genes during the process. We hypothesized that dexamethasone-activates its cognate nuclear receptors inducing up-regulation of erythropoietic genes such as GATA-1, Flk-1, Epo-R, and direct ES cells towards erythropoietic differentiation. ES cells were cultured in primary hematopoietic differentiation media containing methyl-cellulose, IMDM, IL-3, IL-6, and SCF to promote embryoid body (EB) formation. Total RNA of day 3, 5, and 9-old EBs was isolated for gene expression studies using RT-PCR. Cells from day 9 EBs were subjected to secondary differentiation using three different cytokines and growth factors combinations: (1) SCF, EPO, dexamethasone, and IGF; (2) SCF, IL-3, IL-6, and TPO; and, (3) SCF IL-3, IL-6, TPO, and EPO. Total RNA from day 12 of secondary differentiated ES cells was isolated to study the gene expression pattern during this process. Our results demonstrate an up-regulation of GATA-1, Flk-1, HoxB-4, Epo-R, and globin genes (alpha-globin, betaH-1 globin, beta-major globin, epsilon -globin, and zeta-globin) in the 9-day-old EBs, whereas, RNA from 5-day-old EBs showed expression of HoxB-4, epsilon-globin, gamma-globin, betaH1-globin, and Flk-1. Three-day-old EBs showed only HoxB-4 and Flk-1 gene expression and lacked expression of all globin genes. These findings indicate that erythropoiesis-specific genes are activated later in the course of differentiation. Gene expression studies on the ES cells of secondary EB origin cultured in media containing dexamethasone showed a down-regulation of GATA-3 and an up-regulation of GATA-1, Flk-1, and Epo-R in comparison to the two other cytokines and growth factor combinations containing media. The secondary differentiation also showed an enhanced production of erythrocytic precursors in dexamethasone containing media in comparison to that in the control media. Our results indicate that dexamethasone can prove to be an effective agent which can be employed to enhance differentiation towards erythrocytic progenitors from ES cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16764825     DOI: 10.1016/j.bbrc.2006.05.130

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Polycythemia as the first manifestation of Cushing's disease.

Authors:  T Dusek; D Kastelan; M Solak; S Basic Kinda; I Aganovic; M Korsic
Journal:  J Endocrinol Invest       Date:  2008-10       Impact factor: 4.256

2.  Symptom trajectories during chemotherapy in patients with non-small cell lung cancer (NSCLC) and the function of prolonging low dose dexamethasone in promoting enhanced recovery after chemotherapy.

Authors:  Jinghao Liu; Xingyu Liu; Ming Dong; Honglin Zhao; Mei Li; Hongbing Zhang; Huihui Ji; Yi Shi; Yajie Cui; Di Wu; Gang Chen; Jun Chen
Journal:  Thorac Cancer       Date:  2021-01-25       Impact factor: 3.500

3.  Long-Term Hematopoietic Engraftment of Congenic Amniotic Fluid Stem Cells After in Utero Intraperitoneal Transplantation to Immune Competent Mice.

Authors:  Panicos Shangaris; Stavros P Loukogeorgakis; Michael P Blundell; Eleni Petra; Steven W Shaw; Durrgah L Ramachandra; Panagiotis Maghsoudlou; Luca Urbani; Adrian J Thrasher; Paolo De Coppi; Anna L David
Journal:  Stem Cells Dev       Date:  2018-03-27       Impact factor: 3.272

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.